IQ Insigniam Quarterly® Audible
https://quarterly.insigniam.com/IQ Insigniam Quarterly®, a thought leadership magazine in which executives share insights and experiences with breakthrough, innovation, and transformation with other executives. In the face of complex problems and rapid change, business as usual is not enough. To succeed, leaders must breathe life into big ideas and bold commitments. Over thirty years ago, Insigniam pioneered the field of organizational transformation and is a trusted partner to senior executives of the world’s best-run companies for whom speed to breakthrough,innovation and transformation are imperatives.
IQ Insigniam Quarterly® Audible
Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption
July 19, 2022
•
Insigniam
•
Season 3
•
Episode 5
In 2019, Bristol-Myers Squibb Company and Celgene Corporation announced to the world that they had entered into a definitive acquisition agreement. Bristol-Myers Squibb would acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion. It was the largest pharmaceutical acquisition in history.